ASLAN PHARMACEUTICALS LIMITED

Company Listings from SPi: ASLAN PHARMACEUTICALS LIMITED

You are here: Home >> SPi Company Listings >> ASLAN PHARMACEUTICALS LIMITED

 

ASLAN PHARMACEUTICALS LIMITED

Website:
http://

Search for other references to "aslan" on SPi News

Latest ASLAN PHARMACEUTICALS LIMITED News

ASLAN Pharmaceuticals Completes Recruitment for Global Phase 2 Study for Varlitinib in First Line Gastric Cancer SINGAPORE, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN) (TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly pr...... 13:19 GMT Friday 10th August 2018

ASLAN Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update SINGAPORE, Aug. 06, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly pre...... 09:05 GMT Monday 6th August 2018

ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004 SINGAPORE, July 03, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT) (NASDAQ:ASLN), a clinical-stage biopharmaceutical company based in Asia developing novel thera...... 09:01 GMT Tuesday 3rd July 2018

ASLAN Pharmaceuticals to Present Two Posters on Varlitinib at ASCO SINGAPORE, May 17, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT) (Nasdaq:ASLN), a clinical-stage biopharmaceutical company targeting cancers that are both highl...... 07:25 GMT Thursday 17th May 2018

ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares SINGAPORE, May 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (TPEx:6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly preval...... 15:59 GMT Friday 4th May 2018

ASLAN Pharmaceuticals Announces Presentation of New Pre-Clinical Data on Varlitinib in Hepatocellular Carcinoma at AACR SINGAPORE, April 17, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent...... 14:30 GMT Tuesday 17th April 2018

Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S. SINGAPORE, March 26, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent...... 02:00 GMT Tuesday 27th March 2018

Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S. SINGAPORE, March 26, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent...... 02:00 GMT Tuesday 27th March 2018

Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S. SINGAPORE, March 26, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent...... 02:00 GMT Tuesday 27th March 2018

Aslan Pharmaceuticals Files for Proposed Initial Public Offering in the U.S. SINGAPORE, March 26, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN) (6497.TT), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent...... 02:00 GMT Tuesday 27th March 2018

Buy ASLAN PHARMACEUTICALS LIMITED
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers